Partnership to End Addiction
Partnership to End Addiction
Can GLP-1 medications help in addiction treatment?
Can GLP-1 medications help in addiction treatment?
Can GLP-1 medications help in addiction treatment?
Tuesday 23rd September 2025
Explore the potential of GLP-1 medications in addiction treatment with Elizabeth Vargas and Pat Aussem. A possible breakthrough or just hype?
33 minutes
Informative
Hopeful
Inspiring
Encouraging
Engaging
About this podcast
Author:
Partnership to End Addiction
Overview:
Categories:
Family Recovery from Addiction
Sobriety Success Stories
Understanding Addiction & Recovery
Body & Mind
Creative Recovery Journeys
Links:
Visit site
Episodes:
78 (View all)
Do you want to link to this podcast?
Get the buttons here!Could GLP-1 Medications Be the Game-Changer in Addiction Treatment?
Episode Overview
- GLP-1 medications show potential in reducing cravings for alcohol and substances.
- Clinical trials are underway to assess the safety and efficacy of these drugs for addiction.
- Anecdotal evidence suggests promising results, but long-term effects remain unknown.
- Counterfeit drugs pose significant risks; always consult healthcare professionals.
- A pill version of GLP-1 medication may soon become available, increasing accessibility.
"If there were a magic pill that could cure addiction, that would be massive."
What if a medication could help curb addiction? That's the tantalising question Elizabeth Vargas explores with Pat Aussem, Vice President of Consumer Clinical Content Development at Partnership to End Addiction, in this episode of Heart of the Matter. They chat about GLP-1 medications, like Ozempic, originally designed for diabetes and weight loss, and their unexpected potential in treating addiction.
Anecdotal evidence suggests these drugs might reduce cravings for alcohol and other substances, raising hopes for a new approach to addiction treatment. Pat Aussem shares insights into ongoing clinical trials examining the effects of GLP-1 medications on the brain's reward system. With discussions about potential benefits, long-term effects, and accessibility, they delve into the complexities of using these medications as a treatment option.
Elizabeth and Pat also touch on the risks of counterfeit drugs and the importance of consulting healthcare professionals before considering such treatments. The conversation offers a glimpse into the future of addiction treatment, highlighting both optimism and caution. Could these medications be the breakthrough many have been waiting for? While the trials are still underway, there's hope that these findings might change how we view addiction treatment. So, are GLP-1 medications the magic pill we've been searching for?
Only time will tell.